MakCHS Publications

Found 1201 results
Author [ Keyword(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Azithromycin
M. G. Kiddugavu, Kiwanuka, N., Wawer, M. J., Serwadda, D., Sewankambo, N. K., Wabwire-Mangen, F., Makumbi, F., Li, X., Reynolds, S. J., Quinn, T. C., and Gray, R. H., “Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda.”, Sexually transmitted diseases, vol. 32, no. 1, pp. 1-6, 2005.
Bacteria
A. D. Redd, Dabitao, D., Bream, J. H., Charvat, B., Laeyendecker, O., Kiwanuka, N., Lutalo, T., Kigozi, G., Tobian, A. A. R., Gamiel, J., Neal, J. D., Oliver, A. E., Margolick, J. B., Sewankambo, N., Reynolds, S. J., Wawer, M. J., Serwadda, D., Gray, R. H., and Quinn, T. C., “Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa.”, Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 16, pp. 6718-23, 2009.
Bacterial Proteins
P. Ravn, Demissie, A., Eguale, T., Wondwosson, H., Lein, D., Amoudy, H. A., Mustafa, A. S., Jensen, A. K., Holm, A., Rosenkrands, I., Oftung, F., Olobo, J., von Reyn, F., and Andersen, P., “Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.”, The Journal of infectious diseases, vol. 179, no. 3, pp. 637-45, 1999.
M. T. Doherty, Demissie, A., Olobo, J., Wolday, D., Britton, S., Eguale, T., Ravn, P., and Andersen, P., “Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients.”, Journal of clinical microbiology, vol. 40, no. 2, pp. 704-6, 2002.
Base Sequence
I. Lindström, Sundar, N., Lindh, J., Kironde, F., Kabasa, J. D., Kwok, O. C. H., Dubey, J. P., and Smith, J. E., “Isolation and genotyping of Toxoplasma gondii from Ugandan chickens reveals frequent multiple infections.”, Parasitology, vol. 135, no. Pt 1, pp. 39-45, 2008.
Bayes Theorem
R. R. Gray, Tatem, A. J., Lamers, S., Hou, W., Laeyendecker, O., Serwadda, D., Sewankambo, N., Gray, R. H., Wawer, M., Quinn, T. C., Goodenow, M. M., and Salemi, M., “Spatial phylodynamics of HIV-1 epidemic emergence in east Africa.”, AIDS (London, England), vol. 23, no. 14, pp. F9-F17, 2009.
BCG Vaccine
P. Ravn, Demissie, A., Eguale, T., Wondwosson, H., Lein, D., Amoudy, H. A., Mustafa, A. S., Jensen, A. K., Holm, A., Rosenkrands, I., Oftung, F., Olobo, J., von Reyn, F., and Andersen, P., “Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.”, The Journal of infectious diseases, vol. 179, no. 3, pp. 637-45, 1999.
Benzoxazines
E. H. Geng, Neilands, T. B., Thièbaut, R., Bwana, M. Bosco, Nash, D., Moore, R. D., Wood, R., Zannou, D. Marcel, Althoff, K. N., Lim, P. Lian, Nachega, J. B., Easterbrook, P. J., Kambugu, A., Little, F., Nakigozi, G., Nakanjako, D., Kiggundu, V., Li, P. Chung Ki, Bangsberg, D. R., Fox, M. P., Prozesky, H. W., Hunt, P. W., Davies, M. - A., Reynolds, S. J., Egger, M., Yiannoutsos, C. T., Vittinghoff, E. V., Deeks, S. G., and Martin, J. N., “CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa.”, Int J Epidemiol, vol. 44, no. 1, pp. 251-63, 2015.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., “Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women.”, AIDS, vol. 29, no. 2, pp. 183-91, 2015.
Biological Markers
A. D. Redd, Dabitao, D., Bream, J. H., Charvat, B., Laeyendecker, O., Kiwanuka, N., Lutalo, T., Kigozi, G., Tobian, A. A. R., Gamiel, J., Neal, J. D., Oliver, A. E., Margolick, J. B., Sewankambo, N., Reynolds, S. J., Wawer, M. J., Serwadda, D., Gray, R. H., and Quinn, T. C., “Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa.”, Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 16, pp. 6718-23, 2009.
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., “Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?”, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
Biological Transport
A. D. Redd, Dabitao, D., Bream, J. H., Charvat, B., Laeyendecker, O., Kiwanuka, N., Lutalo, T., Kigozi, G., Tobian, A. A. R., Gamiel, J., Neal, J. D., Oliver, A. E., Margolick, J. B., Sewankambo, N., Reynolds, S. J., Wawer, M. J., Serwadda, D., Gray, R. H., and Quinn, T. C., “Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa.”, Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 16, pp. 6718-23, 2009.
Biomedical Research
M. I. Schmidt and Duncan, B. B., “Academic medicine as a resource for global health: the case of Brazil.”, BMJ (Clinical research ed.), vol. 329, no. 7469, pp. 753-4, 2004.
N. Sewankambo, “Academic medicine and global health responsibilities.”, BMJ (Clinical research ed.), vol. 329, no. 7469, pp. 752-3, 2004.
J. van Kammen, de Savigny, D., and Sewankambo, N., “Using knowledge brokering to promote evidence-based policy-making: The need for support structures.”, Bulletin of the World Health Organization, vol. 84, no. 8, pp. 608-12, 2006.
M. Wayengera, Kajumbula, H., and Byarugaba, W., “Identification of restriction endonuclease with potential ability to cleave the HSV-2 genome: inherent potential for biosynthetic versus live recombinant microbicides.”, Theoretical biology & medical modelling, vol. 5, p. 18, 2008.
C. Mgone, Volmink, J., Coles, D., Makanga, M., Jaffar, S., and Sewankambo, N., “Linking research and development to strengthen health systems in Africa.”, Tropical medicine & international health : TM & IH, vol. 15, no. 12, pp. 1404-6, 2010.
Bipolar Disorder
E. Nakimuli-Mpungu, Musisi, S., Mpungu, S. K., and Katabira, E., “Primary mania versus HIV-related secondary mania in Uganda.”, The American journal of psychiatry, vol. 163, no. 8, pp. 1349-54; quiz 1480, 2006.
Blood Specimen Collection
F. Bwanga, Disqué, C., Lorenz, M. G., Allerheiligen, V., Worodria, W., Luyombya, A., Najjingo, I., and Weizenegger, M., “Higher blood volumes improve the sensitivity of direct PCR diagnosis of blood stream tuberculosis among HIV-positive patients: an observation study.”, BMC Infect Dis, vol. 15, p. 48, 2015.
Blood Transfusion
N. Kiwanuka, Gray, R. H., Serwadda, D., Li, X., Sewankambo, N. K., Kigozi, G., Lutalo, T., Nalugoda, F., and Wawer, M. J., “The incidence of HIV-1 associated with injections and transfusions in a prospective cohort, Rakai, Uganda.”, AIDS (London, England), vol. 18, no. 2, pp. 342-4, 2004.
Blood Volume
F. Bwanga, Disqué, C., Lorenz, M. G., Allerheiligen, V., Worodria, W., Luyombya, A., Najjingo, I., and Weizenegger, M., “Higher blood volumes improve the sensitivity of direct PCR diagnosis of blood stream tuberculosis among HIV-positive patients: an observation study.”, BMC Infect Dis, vol. 15, p. 48, 2015.
Blotting, Western
R. H. Gray, Makumbi, F., Serwadda, D., Lutalo, T., Nalugoda, F., Opendi, P., Kigozi, G., Reynolds, S. J., Sewankambo, N. K., and Wawer, M. J., “Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study.”, BMJ (Clinical research ed.), vol. 335, no. 7612, p. 188, 2007.
D. Serwadda, Gray, R. H., Sewankambo, N. K., Wabwire-Mangen, F., Chen, M. Z., Quinn, T. C., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Ashley Morrow, R., and Wawer, M. J., “Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.”, The Journal of infectious diseases, vol. 188, no. 10, pp. 1492-7, 2003.
Body Fat Distribution
M. Bwakura-Dangarembizi, Musiime, V., Szubert, A. J., Prendergast, A. J., Gomo, Z. A., Thomason, M. J., Musarurwa, C., Mugyenyi, P., Nahirya, P., Kekitiinwa, A., Gibb, D. M., Walker, A. S., and Nathoo, K., “Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.”, Pediatr Infect Dis J, vol. 34, no. 2, pp. e23-31, 2015.
Boronic Acids
P. G. Richardson, “Towards a better understanding of treatment-related peripheral neuropathy in multiple myeloma.”, The lancet oncology, vol. 11, no. 11, pp. 1014-6, 2010.
Bottle Feeding
J. Kagaayi, Gray, R. H., Brahmbhatt, H., Kigozi, G., Nalugoda, F., Wabwire-Mangen, F., Serwadda, D., Sewankambo, N., Ddungu, V., Ssebagala, D., Sekasanvu, J., Kigozi, G., Makumbi, F., Kiwanuka, N., Lutalo, T., Reynolds, S. J., and Wawer, M. J., “Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda.”, PloS one, vol. 3, no. 12, p. e3877, 2008.
Brazil
R. S. Wallis, Perkins, M. D., Phillips, M., Joloba, M., Namale, A., Johnson, J. L., Whalen, C. C., Teixeira, L., Demchuk, B., Dietze, R., Mugerwa, R. D., Eisenach, K., and Ellner, J. J., “Predicting the outcome of therapy for pulmonary tuberculosis.”, American journal of respiratory and critical care medicine, vol. 161, no. 4 Pt 1, pp. 1076-80, 2000.
R. S. Wallis, Perkins, M., Phillips, M., Joloba, M., Demchuk, B., Namale, A., Johnson, J. L., Williams, D., Wolski, K., Teixeira, L., Dietze, R., Mugerwa, R. D., Eisenach, K., and Ellner, J. J., “Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment.”, The Journal of infectious diseases, vol. 178, no. 4, pp. 1115-21, 1998.
M. I. Schmidt and Duncan, B. B., “Academic medicine as a resource for global health: the case of Brazil.”, BMJ (Clinical research ed.), vol. 329, no. 7469, pp. 753-4, 2004.
Breast Feeding
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., “Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women.”, AIDS, vol. 29, no. 2, pp. 183-91, 2015.
J. Kagaayi, Gray, R. H., Brahmbhatt, H., Kigozi, G., Nalugoda, F., Wabwire-Mangen, F., Serwadda, D., Sewankambo, N., Ddungu, V., Ssebagala, D., Sekasanvu, J., Kigozi, G., Makumbi, F., Kiwanuka, N., Lutalo, T., Reynolds, S. J., and Wawer, M. J., “Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda.”, PloS one, vol. 3, no. 12, p. e3877, 2008.
Burkina Faso
V. Baraka, Tinto, H., Valea, I., Fitzhenry, R., Delgado-Ratto, C., Mbonye, M. K., Van Overmeir, C., Rosanas-Urgell, A., Van Geertruyden, J. - P., D'Alessandro, U., and Erhart, A., “In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.”, Antimicrob Agents Chemother, vol. 59, no. 1, pp. 734-7, 2015.
Campylobacter
S. E. Mshana, Joloba, M., Kakooza, A., and Kaddu-Mulindwa, D., “Campylobacter spp among children with acute diarrhea attending Mulago hospital in Kampala--Uganda.”, African health sciences, vol. 9, no. 3, pp. 201-5, 2009.
Campylobacter Infections
S. E. Mshana, Joloba, M., Kakooza, A., and Kaddu-Mulindwa, D., “Campylobacter spp among children with acute diarrhea attending Mulago hospital in Kampala--Uganda.”, African health sciences, vol. 9, no. 3, pp. 201-5, 2009.
Capacity Building
A. Elliott, Nerima, B., Bagaya, B., Kambugu, A., Joloba, M., Cose, S., Pantaleo, G., Yazdanbakhsh, M., Mabey, D., Dunne, D., Moffett, A., Rwakishaya, E. Katunguka, Kaleebu, P., and Mbidde, E. Katongole, “Capacity for science in sub-Saharan Africa.”, Lancet, vol. 385, no. 9986, pp. 2435-7, 2015.
Carbon Dioxide
R. S. Wallis, Patil, S., Cheon, S. H., Edmonds, K., Phillips, M., Perkins, M. D., Joloba, M., Namale, A., Johnson, J. L., Teixeira, L., Dietze, R., Siddiqi, S., Mugerwa, R. D., Eisenach, K., and Ellner, J. J., “Drug tolerance in Mycobacterium tuberculosis.”, Antimicrobial agents and chemotherapy, vol. 43, no. 11, pp. 2600-6, 1999.
Case-Control Studies
D. Serwadda, Gray, R. H., Sewankambo, N. K., Wabwire-Mangen, F., Chen, M. Z., Quinn, T. C., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Ashley Morrow, R., and Wawer, M. J., “Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.”, The Journal of infectious diseases, vol. 188, no. 10, pp. 1492-7, 2003.
Catchment Area (Health)
D. Nakanjako, Kamya, M., Daniel, K., Mayanja-Kizza, H., Freers, J., Whalen, C., and Katabira, E., “Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a national referral hospital in Kampala, Uganda.”, AIDS and behavior, vol. 11, no. 5, pp. 753-8, 2007.
Cats
I. Lindström, Sundar, N., Lindh, J., Kironde, F., Kabasa, J. D., Kwok, O. C. H., Dubey, J. P., and Smith, J. E., “Isolation and genotyping of Toxoplasma gondii from Ugandan chickens reveals frequent multiple infections.”, Parasitology, vol. 135, no. Pt 1, pp. 39-45, 2008.
Cause of Death
J. Mugalu, Nakakeeto, M. K., Kiguli, S., and Kaddu-Mulindwa, D. H., “Aetiology, risk factors and immediate outcome of bacteriologically confirmed neonatal septicaemia in Mulago hospital, Uganda.”, African health sciences, vol. 6, no. 2, pp. 120-6, 2006.
CD4 Lymphocyte Count
E. H. Geng, Neilands, T. B., Thièbaut, R., Bwana, M. Bosco, Nash, D., Moore, R. D., Wood, R., Zannou, D. Marcel, Althoff, K. N., Lim, P. Lian, Nachega, J. B., Easterbrook, P. J., Kambugu, A., Little, F., Nakigozi, G., Nakanjako, D., Kiggundu, V., Li, P. Chung Ki, Bangsberg, D. R., Fox, M. P., Prozesky, H. W., Hunt, P. W., Davies, M. - A., Reynolds, S. J., Egger, M., Yiannoutsos, C. T., Vittinghoff, E. V., Deeks, S. G., and Martin, J. N., “CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa.”, Int J Epidemiol, vol. 44, no. 1, pp. 251-63, 2015.
F. Lutwama, Serwadda, R., Mayanja-Kizza, H., Shihab, H. M., Ronald, A., Kamya, M. R., Thomas, D., Johnson, E., Quinn, T. C., Moore, R. D., and Spacek, L. A., “Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy.”, Journal of acquired immune deficiency syndromes (1999), vol. 48, no. 3, pp. 297-303, 2008.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., “Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women.”, AIDS, vol. 29, no. 2, pp. 183-91, 2015.
C. S. Hirsch, Toossi, Z., Johnson, J. L., Luzze, H., Ntambi, L., Peters, P., McHugh, M., Okwera, A., Joloba, M., Mugyenyi, P., Mugerwa, R. D., Terebuh, P., and Ellner, J. J., “Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis.”, The Journal of infectious diseases, vol. 183, no. 5, pp. 779-88, 2001.
H. Brahmbhatt, Kigozi, G., Wabwire-Mangen, F., Serwadda, D., Lutalo, T., Nalugoda, F., Sewankambo, N., Kiduggavu, M., Wawer, M., and Gray, R., “Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda.”, Journal of acquired immune deficiency syndromes (1999), vol. 41, no. 4, pp. 504-8, 2006.
B. Castelnuovo, Manabe, Y. C., Kiragga, A., Kamya, M., Easterbrook, P., and Kambugu, A., “Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.”, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 49, no. 6, pp. 965-72, 2009.
R. Colebunders, Moses, K. R., Laurence, J., Shihab, H. M., Semitala, F., Lutwama, F., Bakeera-Kitaka, S., Lynen, L., Spacek, L., Reynolds, S. J., Quinn, T. C., Viner, B., and Mayanja-Kizza, H., “A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries.”, The Lancet infectious diseases, vol. 6, no. 1, pp. 53-9, 2006.
S. Gianella, Redd, A. D., Grabowski, M. K., Tobian, A. A. R., Serwadda, D., Newell, K., Patel, E. U., Kalibbala, S., Ssebbowa, P., Gray, R. H., Quinn, T. C., and Reynolds, S. J., “Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda.”, J Infect Dis, vol. 212, no. 6, pp. 899-903, 2015.
E. Nakimuli-Mpungu, Musisi, S., Mpungu, S. K., and Katabira, E., “Primary mania versus HIV-related secondary mania in Uganda.”, The American journal of psychiatry, vol. 163, no. 8, pp. 1349-54; quiz 1480, 2006.
CD4-Positive T-Lymphocytes
M. J. Boyle, Jagannathan, P., Bowen, K., McIntyre, T. I., Vance, H. M., Farrington, L. A., Greenhouse, B., Nankya, F., Rek, J., Katureebe, A., Arinaitwe, E., Dorsey, G., Kamya, M. R., and Feeney, M. E., “Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations.”, J Infect Dis, vol. 212, no. 3, pp. 416-25, 2015.
M. A. Eller, Blom, K. G., Gonzalez, V. D., Eller, L. A., Naluyima, P., Laeyendecker, O., Quinn, T. C., Kiwanuka, N., Serwadda, D., Sewankambo, N. K., Tasseneetrithep, B., Wawer, M. J., Gray, R. H., Marovich, M. A., Michael, N. L., de Souza, M. S., Wabwire-Mangen, F., Robb, M. L., Currier, J. R., and Sandberg, J. K., “Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.”, PloS one, vol. 6, no. 4, p. e18779, 2011.
F. Lutwama, Serwadda, R., Mayanja-Kizza, H., Shihab, H. M., Ronald, A., Kamya, M. R., Thomas, D., Johnson, E., Quinn, T. C., Moore, R. D., and Spacek, L. A., “Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy.”, Journal of acquired immune deficiency syndromes (1999), vol. 48, no. 3, pp. 297-303, 2008.
Cell Proliferation
M. A. Eller, Blom, K. G., Gonzalez, V. D., Eller, L. A., Naluyima, P., Laeyendecker, O., Quinn, T. C., Kiwanuka, N., Serwadda, D., Sewankambo, N. K., Tasseneetrithep, B., Wawer, M. J., Gray, R. H., Marovich, M. A., Michael, N. L., de Souza, M. S., Wabwire-Mangen, F., Robb, M. L., Currier, J. R., and Sandberg, J. K., “Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.”, PloS one, vol. 6, no. 4, p. e18779, 2011.
Cell Wall
R. S. Wallis, Perkins, M., Phillips, M., Joloba, M., Demchuk, B., Namale, A., Johnson, J. L., Williams, D., Wolski, K., Teixeira, L., Dietze, R., Mugerwa, R. D., Eisenach, K., and Ellner, J. J., “Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment.”, The Journal of infectious diseases, vol. 178, no. 4, pp. 1115-21, 1998.
Cells, Cultured
P. Ravn, Demissie, A., Eguale, T., Wondwosson, H., Lein, D., Amoudy, H. A., Mustafa, A. S., Jensen, A. K., Holm, A., Rosenkrands, I., Oftung, F., Olobo, J., von Reyn, F., and Andersen, P., “Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.”, The Journal of infectious diseases, vol. 179, no. 3, pp. 637-45, 1999.
C. S. Hirsch, Toossi, Z., Johnson, J. L., Luzze, H., Ntambi, L., Peters, P., McHugh, M., Okwera, A., Joloba, M., Mugyenyi, P., Mugerwa, R. D., Terebuh, P., and Ellner, J. J., “Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis.”, The Journal of infectious diseases, vol. 183, no. 5, pp. 779-88, 2001.
Chickens
I. Lindström, Sundar, N., Lindh, J., Kironde, F., Kabasa, J. D., Kwok, O. C. H., Dubey, J. P., and Smith, J. E., “Isolation and genotyping of Toxoplasma gondii from Ugandan chickens reveals frequent multiple infections.”, Parasitology, vol. 135, no. Pt 1, pp. 39-45, 2008.
Child
M. Bwakura-Dangarembizi, Musiime, V., Szubert, A. J., Prendergast, A. J., Gomo, Z. A., Thomason, M. J., Musarurwa, C., Mugyenyi, P., Nahirya, P., Kekitiinwa, A., Gibb, D. M., Walker, A. S., and Nathoo, K., “Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.”, Pediatr Infect Dis J, vol. 34, no. 2, pp. e23-31, 2015.
M. J. Boyle, Jagannathan, P., Bowen, K., McIntyre, T. I., Vance, H. M., Farrington, L. A., Greenhouse, B., Nankya, F., Rek, J., Katureebe, A., Arinaitwe, E., Dorsey, G., Kamya, M. R., and Feeney, M. E., “Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations.”, J Infect Dis, vol. 212, no. 3, pp. 416-25, 2015.
J. Whitworth, Sewankambo, N. K., and Snewin, V. A., “Improving implementation: building research capacity in maternal, neonatal, and child health in Africa.”, PLoS medicine, vol. 7, no. 7, p. e1000299, 2010.

Pages

The College of Health Sciences is located on Mulago Hill, Mulago, 3 Km from the Kampala City, as is Mulago Hospital. Contact us at the following address:

Office of the Principal,
Makerere University College of Health Sciences,
P.O. Box 7072,
Kampala, Uganda.

Tel: (+256) 41 4530 020
Email pr@chs.mak.ac.ug or the College Principal directly at principal@chs.mak.ac.ug